Skin disorders
Jun 01, 2021
Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec’s Faith in its Chemotherapy-Induced Hearing Loss Drug; Nexturn Bio’s Acquisition of RosVivo
FDA Validates Use of Amgen’s KRAS Inhibitor in Lung Cancer In a pathbreaking move, Amgen has gone ahead to emerge as a trailblazer in the undruggable lung cancer space with the approval of its KRAS inhibitor, Lumakras. For eons, the researchers grappled to come up with an effective and potential drug to ta...
Read More...
Dec 22, 2014
DelveInsight’s Dermatology based Gene Therapy Reports
Gene Therapy: The “Key” to Dermatological disorders! About Dermatological disorders Dermatological disorders comprises of diseases of the skin, scalp, hair, and nails. Apart from being the largest organ in the body, the skin has a vital social function and relatively minor skin complaints often cause more anguish ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
